Brian Taylor Slingsby

Insider Reports History

Location
Radnor, PA
Signature
Catalys Pacific Fund, LP, By: Catalys Pacific Fund GP, LP, its General Partner, By: Catalys Pacific, LLC, its General Partner, By: Brian Taylor Slingsby, its Managing Partner, By: /s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Taylor Slingsby:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director, 10%+ Owner Common Stock 7,910,038 $271,156,102 $34.28 19 Feb 2026 Indirect
Mineralys Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $34.28 19 Feb 2026 Direct
Mineralys Therapeutics, Inc. Director, 10%+ Owner Stock Option 8,300 19 Feb 2026 Indirect
Mineralys Therapeutics, Inc. Director, 10%+ Owner Stock Option 0 19 Feb 2026 Direct

Insider Reports Filed by Brian Taylor Slingsby

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLYS Mineralys Therapeutics, Inc. 19 Feb 2026 6 $0 4 Director, 10%+ Owner 20 Feb 2026, 19:47
MLYS Mineralys Therapeutics, Inc. 20 Nov 2025 1 -$43,350,000 4 Director, 10%+ Owner 21 Nov 2025, 18:07
MLYS Mineralys Therapeutics, Inc. 13 Mar 2025 1 +$3,499,996 4 Director, 10%+ Owner 25 Apr 2025, 19:01
MLYS Mineralys Therapeutics, Inc. 13 Feb 2025 3 $0 4 Director, 10%+ Owner 24 Feb 2025, 18:59
MLYS Mineralys Therapeutics, Inc. 24 Jul 2024 1 -$7,177,500 4 Director, 10%+ Owner 26 Jul 2024, 21:45
MLYS Mineralys Therapeutics, Inc. 22 May 2024 2 $0 4 Director, 10%+ Owner 07 Jan 2025, 17:58
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director, 10%+ Owner 23 May 2024, 16:21
MLYS Mineralys Therapeutics, Inc. 12 Jul 2023 2 $0 4 Director, 10%+ Owner 14 Jul 2023, 08:55
MLYS Mineralys Therapeutics, Inc. 14 Feb 2023 4 +$4,000,000 4 Director, 10%+ Owner 16 Feb 2023, 15:54
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 1 $0 4 Director, 10%+ Owner 13 Feb 2023, 20:03
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 0 $0 3 Director, 10%+ Owner 09 Feb 2023, 18:53